Addus EVP Tucker awarded 3,429 shares, sells 658

Addus HomeCare Corp executive David W. Tucker reported both an equity award and a small share sale.

Rhea-AI Filing Summary

Addus HomeCare Corp executive David W. Tucker reported both an equity award and a small share sale. On February 20, 2026, he acquired 3,429 shares of common stock as a grant or award at no cost. These shares vest in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, subject to continued service and customary change-in-control provisions.

On February 23, 2026, Tucker executed an open-market sale of 658 shares of common stock at $114.91 per share. According to the footnote, this sale was made under a previously established Rule 10b5-1 trading plan adopted on March 13, 2025 and was intended to satisfy tax obligations arising from the vesting of restricted stock awards.

Insider Trade Summary

Net Seller: 658 shares

Net Sell 2 txns

Insider TUCKER DAVID W.

Role EVP, Chief Strategy Officer

Sold 658 shs ($76K)

Type	Security	Shares	Price	Value
Sale	Common Stock	658	$114.91	$76K
Grant/Award	Common Stock	3,429	$0.00	$0.00

Holdings After Transaction: Common Stock — 11,506 shares (Direct)

Footnotes (3)

1. F1. The shares vest in equal installments on each of February 20, 2027, February 20, 2028, and February 20, 2029, subject to customary provisions for continued service and acceleration on a change in control.
2. F2. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.
3. F3. Adoption date of referenced 10b5-1(c) plan is: 03/13/2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Addus HomeCare (ADUS) report for David W. Tucker?

Addus HomeCare reported that EVP and Chief Strategy Officer David W. Tucker received a grant of 3,429 common shares and sold 658 shares. The grant was at no cost, while the sale was an open-market transaction executed under a Rule 10b5-1 trading plan.

How many Addus HomeCare (ADUS) shares were granted to David W. Tucker and on what terms?

David W. Tucker received a grant of 3,429 Addus HomeCare common shares on February 20, 2026. These shares vest in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, contingent on continued service and subject to change-in-control acceleration.

Why did David W. Tucker sell Addus HomeCare (ADUS) shares and at what price?

He sold 658 shares of Addus HomeCare common stock at $114.91 per share on February 23, 2026. A footnote states the sale was under a pre-established Rule 10b5-1 plan to cover tax obligations from vesting restricted stock awards.

Was the Addus HomeCare (ADUS) insider sale by David W. Tucker pre-planned?

Yes, the sale of 658 shares was executed under a previously adopted Rule 10b5-1(c) trading plan. The plan’s adoption date is disclosed as March 13, 2025, indicating the transaction followed a preset trading schedule rather than discretionary timing.

When do David W. Tucker’s new Addus HomeCare (ADUS) restricted shares vest?

The 3,429 granted shares vest in equal parts on February 20, 2027, February 20, 2028, and February 20, 2029. Vesting depends on continued service and includes customary provisions that may accelerate vesting upon a change in control of Addus HomeCare.

What role does David W. Tucker hold at Addus HomeCare (ADUS) in this Form 4?

In this Form 4, David W. Tucker is identified as an officer of Addus HomeCare, serving as Executive Vice President and Chief Strategy Officer. The reported equity award and share sale both relate to his position and compensation as a senior executive of the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 04:02 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TUCKER DAVID W.

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Strategy Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		A		3,429(1)	A	$0	12,164	D
Common Stock	02/23/2026		S(2)(3)		658	D	$114.91	11,506	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares vest in equal installments on each of February 20, 2027, February 20, 2028, and February 20, 2029, subject to customary provisions for continued service and acceleration on a change in control.

2. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.

3. Adoption date of referenced 10b5-1(c) plan is: 03/13/2025

	/s/ Brian Poff, Attorney-in-Fact for David W. Tucker	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.